{
  "ptid_time": "067_S_0056_2017-11-28",
  "img_path": "/data/qiuhui/data/adni/images/067_S_0056/2017-11-28/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 22,390 mm³, 39.4% below the reference mean. With a Z-score of -1.06 (14.4th percentile), this represents mild atrophy; hippocampal volume measures 7,002 mm³, 7.8% above the reference mean. With a Z-score of 0.62 (73.4th percentile), this represents normal volume ; whole brain volume measures 891,990 mm³, 3.9% below the reference mean. With a Z-score of -0.47 (32.0th percentile), this represents normal volume ; entorhinal cortex volume measures 3,771 mm³, 8.9% above the reference mean. With a Z-score of 0.48 (68.5th percentile), this represents normal volume ; fusiform gyrus volume measures 17,639 mm³, 9.5% above the reference mean. With a Z-score of 0.71 (76.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 14,244 mm³, 21.0% below the reference mean. With a Z-score of -1.87 (3.1th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 81.6 years. Gender is Female. Education: 13 years. MMSE: 30.0. MoCA: 21.0. Logical Memory: 8.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 0.99 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows mild ventricular atrophy and moderate atrophy in the middle temporal gyrus, but hippocampal, whole brain, entorhinal cortex, fusiform gyrus, and AV45 amyloid PET (normal) are unremarkable. Despite a normal MMSE (30/30), the MoCA (21/30) suggests cognitive impairment, though APOE4-negative status and normal amyloid reduce Alzheimer's likelihood.  \n**Diagnosis:** **MCI** (due to MoCA impairment and focal temporal atrophy, but not meeting dementia criteria).  \n**Confidence:** **Medium** (atypical profile with mixed imaging and cognitive findings, but amyloid negativity lowers Alzheimer's probability).",
  "timestamp": "2025-07-26T08:23:05.546675"
}